Psychiatric Disorders
Mental illness can have devastating effects not only on patients, but family members and others as well. About one in four adults suffers from a diagnosable mental disorder in a given year, according to the National Institute of Mental Health.
While there are a number of medications available to treat some extremely debilitating psychiatric illnesses, there remains a significant medical need for effective treatments with favorable side effect profiles. Bristol-Myers Squibb focuses on the discovery of effective medications with improved safety and tolerability profiles. Bristol-Myers Squibb received regulatory approval for a
medication to treat psychiatric disorders, and additional investigative drugs are in the development pipeline.